Residency training and clinical and research fellowships at Stanford in Retina, Glaucoma, Cornea, Oculoplastics, Pediatrics and Neuro-Ophthalmology, as well as special fellowships in international health and ophthalmic innovation, together offer exciting opportunities to advance the field and develop careers.
Jeffrey L. Goldberg, MD, PhD
Professor and Chairman
Department of Ophthalmology
Welcome to the Byers Eye Institute in the Department of Ophthalmology, at Stanford University School of Medicine, a top-tier, internationally recognized, multidisciplinary center combining world-class resources with a commitment to providing the highest level of diagnostic and therapeutic care to our patients.
Through an integrated, personalized approach to healthcare delivery, our dedicated team provides the latest therapies in treating eye disorders. Associated with Stanford Health Care, and the Lucille-Packard Children's Hospital, our faculty and staff provide excellence in ocular and vision healthcare to patients across Northern California and from around the world, while our cutting-edge team of researchers carries out some of the most innovative laboratory research and clinical trials anywhere.
Whether you are a patient, a resident, or a leader in academic or clinical ophthalmology, I invite you to explore our programs, visit our clinics and operating rooms, and receive your eye care from our premier faculty.
I am very proud of our exceptional faculty and staff and their accomplishments in our mission areas of patient care, research, education and community outreach.
We are here for you.
We are searching for the best clinicians, clinician-scientists, and vision research scientists to join our faculty at Stanford. If you are looking for staff positions in administration or laboratory or clinical research, please follow this link.
In the News
This course will be organized into didactic and wet lab sessions, covering the theoretical and technical components of MSICS.
Women in Ophthalmology is pleased to invite you to attend our 2022 Summer Symposium, which will take place at Portola Hotel & Spa in Monterey, California, August 25-28, 2022.
Stanford Ophthalmology is leading a pacesetting effort to uncover new glaucoma biomarkers, a key challenge to discovering new breakthroughs in fighting the blinding disease.
It may begin as a few dark specks or wavy lines floating across the field of vision, or lightning-like flashes in the corner of the eye.
Gene therapy, in conjunction with the disruptive technology called Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), has the potential to revolutionize the treatment of previously incurable eye diseases.
In my dreams I was always healthy. In my dreams I could still see, I could drive at night, I could devour books with impunity, and I could pursue goals without constraint.
As virtually anyone who has suffered vision loss can attest, the condition can be life-altering and frightening, potentially affecting one’s mobility, independence, security, and quality of life.
The Stanford Ophthalmology 2021 Annual Report, "Vision Matters: The Eye-Brain Connection" highlights the department's recent news and accomplishments. Click here to read or download the PDF.
The recent issue of Stanford Medicine magazine, a theme issue on eyes and vision, includes details about projects and others pushing the boundaries of biology and technology to help people see. Click here to learn more
Illustration by John Hersey